Cancer Research Horizons on being a ‘facilitator’ and preventing drugs getting stuck in ‘No Man’s Land’
Launching in April last year, Cancer Research Horizons (CRH) describes itself as the “meeting point” between academia and industry, attempting to prevent drug discoveries from entering the ‘valley of death’ and stalling in their progress.
